Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John B Fiveash

Showing results (61-70 of 121) with videos related to

Pageof 13
Sort By:
Advances in Radiation Oncology|October 27, 2025
Preoperative Stereotactic Radiosurgery for Brain Metastases: A Phase 1 Dose Escalation Study Demonstrating Reduced Leptomeningeal DiseaseJohn M Hoyle, James M Markert, Kristen O Riley, et al.
Radiology|September 7, 2016
CT Measures of Bone Mineral Density and Muscle Mass Can Be Used to Predict Noncancer Death in Men with Prostate CancerAndrew M McDonald, Thomas A Swain, David L Mayhew, et al.
Radiation Oncology (London, England)|June 5, 2014
Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapyAndrew M McDonald, Christopher B Baker, Richard A Popple, et al.
Prostate Cancer|September 12, 2012
Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily DosimetryAndrew M McDonald, Justin M Bishop, Rojymon Jacob, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2007
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery aloneStephen M Sawrie, Barton L Guthrie, Sharon A Spencer, et al.
Journal of Neuro-Oncology|July 19, 2014
Cognition in patients with newly diagnosed brain metastasis: profiles and implicationsAdam Gerstenecker, Louis B Nabors, Karen Meneses, et al.
Cancer|June 6, 2006
Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcomaChing-Wei D Tzeng, John B Fiveash, Richard A Popple, et al.
Urology|December 3, 2014
Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapyAndrew M McDonald, Christopher B Baker, Kiran Shekar, et al.
Medical Physics|January 10, 2004
Validation of target volume and position in respiratory gated CT planning and treatmentSui Shen, Jun Duan, John B Fiveash, et al.
Journal of Neuro-Oncology|April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictorsAndrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Pageof 13

Showing results (61-70 of 121) with videos related to

Sort By:
Pageof 13
Advances in Radiation Oncology|October 27, 2025
Preoperative Stereotactic Radiosurgery for Brain Metastases: A Phase 1 Dose Escalation Study Demonstrating Reduced Leptomeningeal DiseaseJohn M Hoyle, James M Markert, Kristen O Riley, et al.
Radiology|September 7, 2016
CT Measures of Bone Mineral Density and Muscle Mass Can Be Used to Predict Noncancer Death in Men with Prostate CancerAndrew M McDonald, Thomas A Swain, David L Mayhew, et al.
Radiation Oncology (London, England)|June 5, 2014
Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapyAndrew M McDonald, Christopher B Baker, Richard A Popple, et al.
Prostate Cancer|September 12, 2012
Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily DosimetryAndrew M McDonald, Justin M Bishop, Rojymon Jacob, et al.
International Journal of Radiation Oncology, Biology, Physics|September 5, 2007
Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery aloneStephen M Sawrie, Barton L Guthrie, Sharon A Spencer, et al.
Journal of Neuro-Oncology|July 19, 2014
Cognition in patients with newly diagnosed brain metastasis: profiles and implicationsAdam Gerstenecker, Louis B Nabors, Karen Meneses, et al.
Cancer|June 6, 2006
Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcomaChing-Wei D Tzeng, John B Fiveash, Richard A Popple, et al.
Urology|December 3, 2014
Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapyAndrew M McDonald, Christopher B Baker, Kiran Shekar, et al.
Medical Physics|January 10, 2004
Validation of target volume and position in respiratory gated CT planning and treatmentSui Shen, Jun Duan, John B Fiveash, et al.
Journal of Neuro-Oncology|April 20, 2022
High-dose methotrexate and rituximab induction regimen in immunocompetent patients with primary CNS lymphoma: a retrospective single-center study of survival predictorsAndrew B DeAtkine, Moaaz Abdelrashid, Zach Tucker, et al.
Pageof 13